1. Lin, K-L, Lin, JJ, Hsia, SH, et al. Effect of antiepileptic drugs for acute and chronic seizures in children with encephalitis. PLoS ONE 2015; 10: e0139974.
Google Scholar | Medline2. Annegers, JF, Hauser, WA, Beghi, E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988; 38: 1407–1410.
Google Scholar | Crossref | Medline3. Fisher, RS, Acevedo, C, Arzimanoglou, A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55: 475–482.
Google Scholar | Crossref | Medline4. Sun, Y, Chen, J, Fang, T, et al. Vagus nerve stimulation therapy for the treatment of seizures in refractory postencephalitic epilepsy: a retrospective study. Front Neurosci 2021; 15: 685685.
Google Scholar | Crossref | Medline5. Pillai, SC, Mohammad, SS, Hacohen, Y, et al. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: clinical and etiologic risk factors. Epilepsia 2016; 57: e7–e11.
Google Scholar | Crossref | Medline6. Trinka, E, Dubeau, F, Andermann, F, et al. Successful epilepsy surgery in catastrophic postencephalitic epilepsy. Neurology 2000; 54: 2170–2173.
Google Scholar | Crossref | Medline7. Marks, DA, Kim, J, Spencer, DD, et al. Characteristics of intractable seizures following meningitis and encephalitis. Neurology 1992; 42: 1513–1518.
Google Scholar | Crossref | Medline8. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures .The Vagus Nerve Stimulation Study Group. Neurology 1995; 45: 224–230.
Google Scholar | Medline9. Ben-Menachem, E, Mañon-Espaillat, R, Ristanovic, R, et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35: 616–626.
Google Scholar | Crossref | Medline10. George, R, Salinsky, M, Kuzniecky, R, et al. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35: 637–643.
Google Scholar | Crossref | Medline11. Toffa, DH, Touma, L, El Meskine, T, et al. Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: a critical review. Seizure 2020; 83: 104–123.
Google Scholar | Crossref | Medline12. Qin, X, Lin, S, Yuan, Y, et al. Vagus nerve stimulation for pediatric patients with drug-resistant epilepsy caused by genetic mutations: two cases. J Neurorestoratol 2020; 8: 138–148.
Google Scholar | Crossref13. Suller Marti, A, Mirsattari, SM, MacDougall, K, et al. Vagus nerve stimulation in patients with therapy-resistant generalized epilepsy. Epilepsy Behav 2020; 111: 107253.
Google Scholar | Crossref | Medline14. Specchio, N, Ferretti, A, Pietrafusa, N, et al. Refractory status epilepticus in genetic epilepsy-is vagus nerve stimulation an option? Front Neurol 2020; 11: 443.
Google Scholar | Crossref | Medline15. Dibué-Adjei, M, Fischer, I, Steiger, HJ, et al. Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: a meta-analysis of 68 patients. Seizure 2017; 50: 147–152.
Google Scholar | Crossref | Medline16. Ramsay, RE, Uthman, BM, Augustinsson, LE, et al. Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35: 627–636.
Google Scholar | Crossref | Medline17. Orosz, I, McCormick, D, Zamponi, N, et al. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia 2014; 55: 1576–1584.
Google Scholar | Crossref | Medline18. Zhu, J, Xu, C, Zhang, X, et al. Epilepsy duration as an independent predictor of response to vagus nerve stimulation. Epilepsy Res 2020; 167: 106432.
Google Scholar | Crossref | Medline19. Soleman, J, Stein, M, Knorr, C, et al. Improved quality of life and cognition after early vagal nerve stimulator implantation in children. Epilepsy Behav 2018; 88: 139–145.
Google Scholar | Crossref | Medline20. Liu, H, Yang, Z, Huang, L, et al. Heart-rate variability indices as predictors of the response to vagus nerve stimulation in patients with drug-resistant epilepsy. Epilepsia 2017; 58: 1015–1022.
Google Scholar | Crossref | Medline21. Englot, DJ, Chang, EF, Auguste, KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg 2011; 115: 1248–1255.
Google Scholar | Crossref | Medline22. Elliott, RE, Morsi, A, Kalhorn, SP, et al. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav 2011; 20: 57–63.
Google Scholar | Crossref | Medline23. Burakgazi, AZ, Burakgazi-Dalkilic, E, Caputy, AJ, et al. The correlation between vagus nerve stimulation efficacy and partial onset epilepsies. J Clin Neurophysiol 2011; 28: 380–383.
Google Scholar | Crossref | Medline24. Meador, KJ, Kapur, R, Loring, DW, et al. Quality of life and mood in patients with medically intractable epilepsy treated with targeted responsive neurostimulation. Epilepsy Behav 2015; 45: 242–247.
Google Scholar | Crossref | Medline25. Wan, L, Li, Z, Sun, Y, et al. Clinical characteristics and treatment outcomes of pediatric patients with postencephalitic epilepsy characterized by epileptic spasms. Seizure 2021; 84: 116–121.
Google Scholar | Crossref | Medline26. Knorr, C, Greuter, L, Constantini, S, et al. Subgroup analysis of seizure and cognitive outcome after vagal nerve stimulator implantation in children. Childs Nerv Syst 2021; 37: 243–252.
Google Scholar | Crossref | Medline27. Trinka, E, Dubeau, F, Andermann, F, et al. Clinical findings, imaging characteristics and outcome in catastrophic post-encephalitic epilepsy. Epileptic Disord 2000; 2: 153–162.
Google Scholar | Medline28. Lin, JJ, Hsia, SH, Wu, CT, et al. Mycoplasma pneumoniae-related postencephalitic epilepsy in children. Epilepsia 2011; 52: 1979–1985.
Google Scholar | Crossref | Medline29. Singh, TD, Fugate, JE, Hocker, SE, et al. Postencephalitic epilepsy: clinical characteristics and predictors. Epilepsia 2015; 56: 133–138.
Google Scholar | Crossref | Medline30. Rismanchi, N, Gold, JJ, Sattar, S, et al. Epilepsy after resolution of presumed childhood encephalitis. Pediatr Neurol 2015; 53: 65–72.
Google Scholar | Crossref | Medline31. Kwan, P, Arzimanoglou, A, Berg, AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069–1077.
Google Scholar | Crossref | Medline32. Révész, D, Rydenhag, B, Ben-Menachem, E. Complications and safety of vagus nerve stimulation: 25 years of experience at a single center. J Neurosurg Pediatr 2016; 18: 97–104.
Google Scholar | Crossref | Medline33. Heck, C, Helmers, SL, DeGiorgio, CM. Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 2002; 59: S31–S37.
Google Scholar | Crossref | Medline34. Kim, MJ, Yum, MS, Kim, EH, et al. An interictal EEG can predict the outcome of vagus nerve stimulation therapy for children with intractable epilepsy. Childs Nerv Syst 2017; 33: 145–151.
Google Scholar | Crossref | Medline35. Graus, F, Titulaer, MJ, Balu, R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15: 391–404.
Google Scholar | Crossref | Medline36. Scheffer, IE, Berkovic, S, Capovilla, G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 512–521.
Google Scholar | Crossref | Medline37. Rodgers, WP, Durnford, AJ, Kirkham, FJ, et al. Interrater reliability of Engel, International League Against Epilepsy, and McHugh seizure outcome classifications following vagus nerve stimulator implantation. J Neurosurg Pediatr 2012; 10: 226–229.
Google Scholar | Crossref | Medline38. Hodl, S, Carrette, S, Meurs, A, et al. Neurophysiological investigations of drug resistant epilepsy patients treated with vagus nerve stimulation to differentiate responders from non-responders. Eur J Neurol 2020; 27: 1178–1189.
Google Scholar | Crossref | Medline39. Jain, P, Arya, R. Vagus nerve stimulation and seizure outcomes in pediatric refractory epilepsy: systematic review and meta-analysis. Neurology 2021; 96: 1041–1051.
Google Scholar | Crossref40. Kawai, K, Tanaka, T, Baba, H, et al. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry. Epileptic Disord 2017; 19: 327–338.
Google Scholar | Crossref | Medline41. Ulate-Campos, A, Cean-Cabrera, L, Petanas-Argemi, J, et al. Vagus nerve stimulator implantation for epilepsy in a paediatric hospital: outcomes and effect on quality of life. Neurologia 2015; 30: 465–471.
Google Scholar | Crossref | Medline42. Frost, M, Gates, J, Helmers, SL, et al. Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia 2001; 42: 1148–1152.
Google Scholar | Crossref | Medline43. Abdelmoity, SA, Abdelmoity, AA, Riordan, SM, et al. The efficacy and tolerability of auto-stimulation-VNS in children with Lennox-Gastaut syndrome. Seizure 2021; 86: 168–174.
Google Scholar | Crossref | Medline44. Dibué, M, Greco, T, Spoor, JKH, et al. Vagus nerve stimulation in patients with Lennox-Gastaut syndrome: a meta-analysis. Acta Neurol Scand 2021; 143: 497–508.
Google Scholar | Crossref | Medline45. Youn, SE, Jung, DE, Kang, HC, et al. Long-term results of vagus nerve stimulation in children with Dravet syndrome: time-dependent, delayed antiepileptic effect. Epilepsy Res 2021; 174: 106665.
Google Scholar | Crossref | Medline46. Li, ST, Chiu, NC, Hung, KL, et al. Therapeutic effects of children with refractory epilepsy after vagus nerve stimulation in Taiwan. Pediatr Neonatol 2020; 61: 606–612.
Google Scholar | Crossref | Medline47. Yu, C, Ramgopal, S, Libenson, M, et al. Outcomes of vagal nerve stimulation in a pediatric population: a single center experience. Seizure 2014; 23: 105–111.
Google Scholar | Crossref | Medline48. Labar, D, Murphy, J, Tecoma, E. Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group. Neurology 1999; 52: 1510–1512.
Google Scholar | Crossref | Medline49. Labar, D . Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs. Seizure 2004; 13: 392–398.
Google Scholar | Crossref | Medline50. Workewych, AM, Arski, ON, Mithani, K, et al. Biomarkers of seizure response to vagus nerve stimulation: a scoping review. Epilepsia 2020; 61: 2069–2085.